Background
What it is, how it developed and why it is discussed
BPC-157 is a synthetic 15-amino-acid peptide modelled on a fragment associated with gastric proteins. Most published work exploring tissue protection and repair has been preclinical rather than large, controlled human trials.
Evidence
Evidence, limitations and clinical context
Human evidence remains limited. SAHPRA specifically lists BPC-157 among peptides being illegally marketed in South Africa; this site therefore does not enable ordinary online sale of BPC-157.
Clinical access
Not available for routine online purchase
This treatment is not enabled for routine online sale. A doctor can discuss the evidence, suitability and lawful alternatives. Where an unregistered medicine is considered clinically necessary, any access must follow the applicable SAHPRA authorisation process before supply.
Clinical assessment Clinician authorisation
